China Sky One Medical, Inc. (AMEX:
CSY)
reported it received SFDA approval for five new patch products, most of
them using natural herbs as their active ingredients. They include:
• Anti-smoking patch -- breaks down nicotine and other harmful chemical
compounds related to cigarette smoking and reduces dependence on
cigarettes;
• Scar patch -- speeds up the healing of the wounds due to trauma and
surgeries and reduces the likelihood of developing permanent scars;
• Migraine patch -- provides quick pain relief for migraine sufferers while alleviating dizziness and nausea;
• Eye patch -- relaxes the muscles in the retina, which helps to reduce the likelihood of developing myopia;
• Coronary heart disease patch -- increases blood circulation in
coronary arteries, which reduces the incidences of coronary heart
disease and myocardial infarction.
The company stressed that the products, which were developed following
rigorous market research, do not have the side-effects associated with
chemical-based patch products. Unlike most anti-smoking patches, for
example, the China Sky One patch does not supply the body with
nicotine. China Sky One already had orders for some of the products,
including the smoking patch, before it received a permit to begin
production.
China Sky One has an additional ten products in development targeting the global market.
Also, China Sky One has completed its previously announced transition
to the American Stock Exchange, and now trades under the symbol CSY.
